Local drug makers to be hit by patent suits

Korean drug firms would face an uphill battle in patent infringement lawsuits as the Korea-U.S. free trade agreement (KORUS FTA) went into effect Thursday, citing the need for effective policy to support them.

According to data released by the Korean Intellectual Property Office and the Korea Intellectual Right Protection Association, the number of patent suits lodged by the U.S. based Gile...